Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael K Brawer

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Current Medical Research and Opinion|March 1, 2014
Cell cycle progression score and treatment decisions in prostate cancer: results from an ongoing registryE David Crawford, Mark C Scholz, Ashok J Kar, et al.
The Journal of Urology|November 21, 2002
Attitudes and use of complementary medicine in men with prostate cancerSimon Wilkinson, Leonard G Gomella, Joseph A Smith, et al.
The New England Journal of Medicine|July 13, 2017
Follow-up of Prostatectomy versus Observation for Early Prostate CancerTimothy J Wilt, Karen M Jones, Michael J Barry, et al.
Abdominal Radiology (New York)|April 29, 2019
Extracapsular extension on MRI indicates a more aggressive cell cycle progression genotype of prostate cancerAndreas G Wibmer, Nicola L Robertson, Hedvig Hricak, et al.
Current Medical Research and Opinion|December 11, 2013
Clinical utility of a biopsy-based cell cycle gene expression assay in localized prostate cancerNeal Shore, Raoul Concepcion, Daniel Saltzstein, et al.
Cancer|October 30, 2003
A neurocomputational model for prostate carcinoma detectionPankaj Kalra, Joanna Togami, Gaurav Bansal B S, et al.
European Urology|February 25, 2020
Radical Prostatectomy or Observation for Clinically Localized Prostate Cancer: Extended Follow-up of the Prostate Cancer Intervention Versus Observation Trial (PIVOT)Timothy J Wilt, Tien N Vo, Lisa Langsetmo, et al.
Clinical Genitourinary Cancer|February 20, 2021
Personalizing Localized Prostate Cancer: Validation of a Combined Clinical Cell-cycle Risk (CCR) Score Threshold for Prognosticating Benefit From Multimodality TherapyJonathan D Tward, Thorsten Schlomm, Stephen Bardot, et al.
Controlled Clinical Trials|April 12, 2003
Study design of the Medical Therapy of Prostatic Symptoms (MTOPS) trialOliver M Bautista, John W Kusek, Leroy M Nyberg, et al.
The Journal of Urology|September 26, 2015
Impact of the Cell Cycle Progression Test on Physician and Patient Treatment Selection for Localized Prostate CancerNeal D Shore, Naveen Kella, Brian Moran, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Current Medical Research and Opinion|March 1, 2014
Cell cycle progression score and treatment decisions in prostate cancer: results from an ongoing registryE David Crawford, Mark C Scholz, Ashok J Kar, et al.
The Journal of Urology|November 21, 2002
Attitudes and use of complementary medicine in men with prostate cancerSimon Wilkinson, Leonard G Gomella, Joseph A Smith, et al.
The New England Journal of Medicine|July 13, 2017
Follow-up of Prostatectomy versus Observation for Early Prostate CancerTimothy J Wilt, Karen M Jones, Michael J Barry, et al.
Abdominal Radiology (New York)|April 29, 2019
Extracapsular extension on MRI indicates a more aggressive cell cycle progression genotype of prostate cancerAndreas G Wibmer, Nicola L Robertson, Hedvig Hricak, et al.
Current Medical Research and Opinion|December 11, 2013
Clinical utility of a biopsy-based cell cycle gene expression assay in localized prostate cancerNeal Shore, Raoul Concepcion, Daniel Saltzstein, et al.
Cancer|October 30, 2003
A neurocomputational model for prostate carcinoma detectionPankaj Kalra, Joanna Togami, Gaurav Bansal B S, et al.
European Urology|February 25, 2020
Radical Prostatectomy or Observation for Clinically Localized Prostate Cancer: Extended Follow-up of the Prostate Cancer Intervention Versus Observation Trial (PIVOT)Timothy J Wilt, Tien N Vo, Lisa Langsetmo, et al.
Clinical Genitourinary Cancer|February 20, 2021
Personalizing Localized Prostate Cancer: Validation of a Combined Clinical Cell-cycle Risk (CCR) Score Threshold for Prognosticating Benefit From Multimodality TherapyJonathan D Tward, Thorsten Schlomm, Stephen Bardot, et al.
Controlled Clinical Trials|April 12, 2003
Study design of the Medical Therapy of Prostatic Symptoms (MTOPS) trialOliver M Bautista, John W Kusek, Leroy M Nyberg, et al.
The Journal of Urology|September 26, 2015
Impact of the Cell Cycle Progression Test on Physician and Patient Treatment Selection for Localized Prostate CancerNeal D Shore, Naveen Kella, Brian Moran, et al.
Pageof 4